← Back to Clinical Trials
Recruiting NCT06640751

The Effect of Interventions for Health Behaviors in Hypertensive Patients

Trial Parameters

Condition Hypertension
Sponsor Nanjing Medical University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 240
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2024-10-01
Completion 2025-05
Interventions
Health behavior intervention

Brief Summary

Hypertension is a major risk factor for cardiovascular disease, chronic kidney disease, and premature death worldwide. With an aging population and changes in dietary patterns and lifestyles, the prevalence of hypertension is rising globally, especially in developing countries. Hypertension is the most common chronic disease and a growing public health problem in China. A recent study estimated the prevalence of hypertension to be 28.56 % ± 10.44 %, ranging from 14.28% to 44.28% among the Chinese population aged over 15 years. The PRECEED-PROCEDE model provides a framework to help health planners and policymakers design effective health interventions based on evaluation and analysis of situations. This model has been used in different recent studies related to behavioral change. The study aims to examine the effectiveness of interventions for health behaviors in hypertensive patients based on the PRECEDE-PROCEED model.

Eligibility Criteria

Inclusion Criteria: 1. Patients diagnosed with mild to moderate primary hypertension according to the diagnostic criteria of the "2018 Revised Edition of the Chinese Guidelines for the Prevention and Treatment of Hypertension," whose blood pressure is not well controlled or who have poor treatment compliance; 2. Age greater than 18 years and less than 80 years; 3. Normal language communication ability and willingness to participate in the study; 4. Have lived in the community for at least 12 months. Exclusion Criteria: 1. Patients who lack basic behavioral abilities, have impaired memory function, or have limited language expression abilities; 2. Patients who are simultaneously participating in other intervention studies.

Related Trials